Total Payments
$161,571
2024 Payments
$10,953
Companies
12
Transactions
278
Medicare Patients
1,476
Medicare Billing
$191,664
Payment Breakdown by Category
Other$135,500 (83.9%)
Travel$15,584 (9.6%)
Food & Beverage$5,425 (3.4%)
Consulting$4,700 (2.9%)
Education$362.07 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $135,500 | 66 | 83.9% |
| Travel and Lodging | $15,584 | 64 | 9.6% |
| Food and Beverage | $5,425 | 139 | 3.4% |
| Consulting Fee | $4,700 | 2 | 2.9% |
| Education | $362.07 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Products, LP | $98,190 | 113 | $0 (2023) |
| Gilead Sciences, Inc. | $59,749 | 83 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,560 | 1 | $0 (2021) |
| Emergent Biosolutions Inc. | $804.46 | 3 | $0 (2017) |
| Janssen Biotech, Inc. | $538.49 | 39 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $350.71 | 23 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $181.00 | 10 | $0 (2017) |
| Stryker Corporation | $100.99 | 1 | $0 (2019) |
| PFIZER INC. | $30.14 | 2 | $0 (2021) |
| AbbVie Inc. | $27.62 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,953 | 14 | Gilead Sciences, Inc. ($10,953) |
| 2023 | $17,904 | 28 | Gilead Sciences, Inc. ($10,847) |
| 2022 | $12,652 | 15 | Janssen Products, LP ($9,868) |
| 2021 | $11,386 | 23 | Janssen Products, LP ($6,305) |
| 2020 | $41.90 | 3 | Janssen Biotech, Inc. ($41.90) |
| 2019 | $43,823 | 62 | Janssen Products, LP ($26,185) |
| 2018 | $34,409 | 56 | Janssen Products, LP ($28,497) |
| 2017 | $30,401 | 77 | Janssen Products, LP ($20,391) |
All Payment Transactions
278 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: HIV | ||||||
| 09/06/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: HIV | ||||||
| 05/16/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,570.00 | General |
| Category: HIV | ||||||
| 05/13/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $69.68 | General |
| Category: HIV | ||||||
| 05/13/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $37.49 | General |
| Category: HIV | ||||||
| 05/08/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: HIV | ||||||
| 05/08/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $146.24 | General |
| Category: HIV | ||||||
| 05/01/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $121.64 | General |
| Category: HIV | ||||||
| 04/02/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,210.00 | General |
| Category: HIV | ||||||
| 03/22/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $307.77 | General |
| Category: HIV | ||||||
| 03/22/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: HIV | ||||||
| 03/22/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: HIV | ||||||
| 03/21/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $298.10 | General |
| Category: HIV | ||||||
| 03/21/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $112.34 | General |
| Category: HIV | ||||||
| 12/15/2023 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $370.00 | General |
| Category: HIV | ||||||
| 10/12/2023 | Janssen Products, LP | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $50.95 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 10/10/2023 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| 10/04/2023 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $93.05 | General |
| 10/02/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $122.01 | General |
| 09/26/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/20/2023 | Janssen Products, LP | SYMTUZA (Drug) | Travel and Lodging | Cash or cash equivalent | $168.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/18/2023 | Janssen Products, LP | SYMTUZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,535.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/20/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/30/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.65 | General |
| Category: Cardiovascular | ||||||
| 06/06/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: Infectious Diseases & Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 286 | 493 | $192,925 | $39,389 |
| 2022 | 5 | 309 | 576 | $203,700 | $42,049 |
| 2021 | 5 | 359 | 613 | $205,325 | $44,727 |
| 2020 | 6 | 522 | 842 | $302,475 | $65,498 |
Total Patients
1,476
Total Services
2,524
Medicare Billing
$191,664
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 133 | 154 | $100,100 | $22,428 | 22.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 78 | 197 | $44,325 | $8,207 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 42 | 83 | $24,900 | $4,288 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 48 | $19,200 | $3,697 | 19.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 11 | 11 | $4,400 | $770.22 | 17.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 113 | 122 | $79,300 | $20,612 | 26.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 94 | 234 | $52,650 | $7,666 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 56 | 140 | $40,250 | $7,426 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 35 | 69 | $27,100 | $5,556 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 11 | 11 | $4,400 | $789.25 | 17.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 109 | 120 | $78,000 | $20,596 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 80 | 167 | $41,750 | $8,913 | 21.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 110 | 233 | $52,425 | $7,729 | 14.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 48 | 81 | $28,350 | $6,616 | 23.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 12 | 12 | $4,800 | $874.56 | 18.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 207 | 220 | $143,000 | $38,665 | 27.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 163 | 377 | $84,825 | $12,778 | 15.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 52 | 98 | $34,300 | $6,328 | 18.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 64 | 104 | $26,000 | $4,574 | 17.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 24 | 31 | $7,750 | $1,714 | 22.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $6,600 | $1,439 | 21.8% |
About Dr. Thomas Treadwell, M.D
Dr. Thomas Treadwell, M.D is a Internal Medicine healthcare provider based in Framingham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144260670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Treadwell, M.D has received a total of $161,571 in payments from pharmaceutical and medical device companies, with $10,953 received in 2024. These payments were reported across 278 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($135,500).
As a Medicare-enrolled provider, Treadwell has provided services to 1,476 Medicare beneficiaries, totaling 2,524 services with total Medicare billing of $191,664. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Framingham, MA
- Active Since 06/06/2006
- Last Updated 01/18/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144260670
Products in Payments
- PREZCOBIX (Drug) $29,481
- Symtuza (Drug) $29,404
- Biktarvy (Drug) $26,303
- SYMTUZA (Drug) $24,949
- Genvoya (Drug) $4,524
- Descovy (Drug) $4,373
- ELIQUIS (Drug) $282.98
- ISENTRESS (Drug) $162.60
- MAKO (Device) $100.99
- CAMZYOS (Drug) $50.88
- DALVANCE (Drug) $27.62
- TRIUMEQ (Drug) $22.71
- PNEUMOVAX 23 (Biological) $18.40
- Imbruvica (Drug) $15.86
- CHANTIX (Drug) $14.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Framingham
Dr. Zarmeneh Aly, M.d, M.D
Internal Medicine — Payments: $2,243
Internal Medicine $2,243
Irma Rasmussen, Md, MD
Internal Medicine — Payments: $2,107
Internal Medicine $2,107
Elman Urbina Meneses, Md, MD
Internal Medicine — Payments: $2,019
Internal Medicine $2,019
Dr. Wajih Syed, M.d, M.D
Internal Medicine — Payments: $2,010
Internal Medicine $2,010
Dr. Sew-Leong Kwa, Mbbs Pc, MBBS PC
Internal Medicine — Payments: $1,999
Internal Medicine $1,999
Jason Konter, M.d, M.D
Internal Medicine — Payments: $1,781
Internal Medicine $1,781